Notice of Effectiveness (effect)
May 18 2022 - 5:08AM
Edgar (US Regulatory)
UNITED STATES
|
---|
SECURITIES AND EXCHANGE COMMISSION
|
---|
Washington, D.C. 20549
|
---|
NOTICE OF EFFECTIVENESS |
---|
|
Effective Date: | May 17,
2022 |
---|
Accession Number: | 0001193125-22-066056 |
---|
Submission Type: | POS AM |
---|
CIK: | 0001662774 |
---|
Company Name: | Cortexyme, Inc. |
---|
File Number: | 333-238851 |
---|
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Apr 2023 to Apr 2024